SEC Form D · filed July 15, 2024
CASI Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (31)
Chunhua Y. Wang · Beijing, IsraelExecWei Y. Gao · Beijing, IsraelExecAlexander Y. Wu · Rockville, MDDirectorZhenbo Su · Beijing, IsraelDirectorHai Y. Huang · Beijing, IsraelExecKun Y. Qian · Beijing, IsraelExecThomas Folinsbee · Beijing, IsraelDirectorXuebo Y. Zeng · Beijing, IsraelDirectorWei-Wu He · Beijing, IsraelExec · DirectorChunhua Y. Wang · Beijing, IsraelExecWei Y. Gao · Beijing, IsraelExecAlexander Y. Wu · Rockville, MDDirectorZhenbo Su · Beijing, IsraelDirectorHai Y. Huang · Beijing, IsraelExecKun Y. Qian · Beijing, IsraelExecThomas Folinsbee · Beijing, IsraelDirectorXuebo Y. Zeng · Beijing, IsraelDirectorAlexander A. Zukiwski · Rockville, MDExecWei (Larry) Y. Zhang · Beijing, IsraelExecWei-Wu He · ROCKVILLE, MDExec · DirectorTimothy P. Sullivan · Chicago, ILExecMichael J. Dolce · Chicago, ILExecThomas S. Souleles · Chicago, ILDirectorAnnie S. Terry · Chicago, ILDirectorMatthew J. Denison · Chicago, ILExecBrendan J. Barrett · Chicago, ILExecBrandon J. Levitan · Chicago, ILDirectorJonathan C. Cohen · London, United KingdomDirectorSandra Crane · London, United KingdomExec · DirectorAlexander A. Zukiwski · Rockville, MDExecWei (Larry) Y. Zhang · Beijing, IsraelExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗